Teladoc Health, Inc. TDOC recently entered into a definitive merger agreement with Livongo Health , Inc. LVGO , which is an Applied Health Signals company. Subject to customary approval, the cash-stock transaction valued at $18.5 billion is likely to conclude by the end of fourth-quarter 2020.
Upon closure of the transaction, the existing shareholders of Teladoc Health and Livongo will own around 58% and 42%, respectively, of the combined company.
Benefits of the Deal
The merger of the companies, both of which already excel in virtual health and chronic condition management, will create a comprehensive virtual healthcare delivery system. This, in turn, will result in improved health outcomes and reduced costs across the healthcare ecosystem.
Moreover, the platform of the combined company will be equipped with AI+AI engine-driven “nudges”, health coaches, therapists, board-certified physicians and specialists. The platform will also provide consumers access to real-time information and demonstrate ways to manage their well-being.